Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values

K Dhama, SK Latheef, M Dadar, HA Samad… - Frontiers in molecular …, 2019 - frontiersin.org
Various internal and external factors negatively affect the homeostatic equilibrium of
organisms at the molecular to the whole-body level, inducing the so-called state of stress …

Novel biomarkers in hepatocellular carcinoma

F De Stefano, E Chacon, L Turcios, F Marti… - Digestive and Liver …, 2018 - Elsevier
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths and
the fifth most common cancer worldwide. Most of these patients are seen with advanced …

Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis

Y Wang, Z Liu, B Yao, Q Li, L Wang, C Wang, C Dou… - Molecular cancer, 2017 - Springer
Background Recently, it has been reported that long non-coding RNA (lncRNA) cancer
susceptibility candidate 2 (CASC2), a novel tumor suppressor, participates in regulating the …

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients

N Ratnasari, P Lestari, D Renovaldi… - PLoS …, 2022 - journals.plos.org
This study evaluated differences in the clinical appearance of patients with hepatocellular
carcinoma (HCC) based on plasma level and regulation of microRNAs (miRNA-29c, miRNA …

An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly

H Wang, M Shen, X Shen, J Liu, W Huang… - Biosensors and …, 2024 - Elsevier
MicroRNA (miRNA) is demonstrated to be associated with the occurrence and development
of various diseases including cancer. Currently, most miRNA detection methods are …

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

W Okajima, S Komatsu, D Ichikawa… - World Journal of …, 2017 - pmc.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), with its high incidence and mortality rate, is one of the
most common malignant tumors. Despite recent development of a diagnostic and treatment …

The regulatory role of microRNA in hepatitis-B virus-associated hepatocellular carcinoma (HBV-HCC) pathogenesis

K Sartorius, J Makarova, B Sartorius, P An, C Winkler… - Cells, 2019 - mdpi.com
The incidence and mortality of hepatitis B virus (HBV)-associated hepatocellular carcinoma
(HBV-HCC) is an intractable public health problem in develo** countries that is …

[HTML][HTML] Microcystin-LR in primary liver cancers: an overview

S Gu, M Jiang, B Zhang - Toxins, 2022 - mdpi.com
The cyanobacterial blooms produced by eutrophic water bodies have become a serious
environmental issue around the world. After cellular lysing or algaecide treatment …

A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer

F Matin, V Jeet, L Moya, LA Selth, S Chambers… - Scientific reports, 2018 - nature.com
Prostate cancer is diagnosed in over 1 million men every year globally, yet current
diagnostic modalities are inadequate for identification of significant cancer and more reliable …

Emerging role of exosomal microRNA in liver cancer in the era of precision medicine; potential and challenges

T El Hayek, OA Alnaser-Almusa… - Frontiers in Molecular …, 2024 - frontiersin.org
Exosomal microRNAs (miRNAs) have great potential in the fight against hepatocellular
carcinoma (HCC), the fourth most common cause of cancer-related death worldwide. In this …